NCT06790160
Registry title: Study of Patients Being Treated With Anti-obesity Medication
- Study-level overall status
- RECRUITING
- Record update date
Exact-matched listed facility/location
- Texas Tech UniversityLubbock, Texas 79409
ClinicalTrials.gov research records
ClinicalTrials.gov research-record snapshot for Lubbock, TX
Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 1 result; after an exact city/state check of listed facilities, 1 record were retained for Lubbock, Texas. It is not a clinic, enrollment, or local-availability directory.
Snapshot methodology and exact-location matching
- City/state source filter
- Lubbock, Texas
- Exact-location inclusion rule
- A listed facility city and state must match Lubbock, Texas.
Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.
Fixed query terms
- semaglutide
- tirzepatide
- cagrilintide
- retatrutide
- tesamorelin
- sermorelin
- ipamorelin
- bpc-157
- thymosin alpha 1
- pt-141
Included study statuses
- RECRUITING
- NOT_YET_RECRUITING
- ACTIVE_NOT_RECRUITING
- ENROLLING_BY_INVITATION
How to read this snapshot
Research-record limits
- This is not a clinic, enrollment, local-service, or local-availability directory.
- Why Peptides does not recommend sites, assess eligibility, or provide medical advice.
- A listing or study-level status does not prove enrollment, eligibility, safety, effectiveness, or availability.
- Each displayed registry status is a study-level overall status, not a facility enrollment status.
- Links on this page lead only to the cited ClinicalTrials.gov source records and search pages.
- Records are a fixed snapshot, not a complete or live catalog.
All retained records
Study-level status mix
The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.
- RECRUITING
- 1 record
- NOT_YET_RECRUITING
- 0 records
- ACTIVE_NOT_RECRUITING
- 0 records
- ENROLLING_BY_INVITATION
- 0 records
Records in this snapshot
Retained ClinicalTrials.gov NCT records
The retrieved source snapshot contains 1 exact-location record and 1 listed facility. All 1 retained records are shown below.
Source retrieval and snapshot limits
Source-query results versus exact-location records
At retrieval, the fixed ClinicalTrials.gov source query returned 1 result. After an exact city/state check of listed facilities, 1 record were retained for Lubbock, Texas, across 1 listed facility. All 1 retained records are shown on this page.
- Source retrieved
- Record update dates
- Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
- Source-query results
- 1
- Exact-location records retained
- 1
- Listed facilities retained
- 1
- Records shown
- 1 of 1
Fixed ClinicalTrials.gov source query (JSON)
Broader live ClinicalTrials.gov search (no status filter)
Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.
Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.